Clinical Trial

REVIVE Prospective Registry Cohort Study

Name: REVIVE Prospective Registry Cohort Study — clinical trial record (NCT07429890)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The main purpose of this registry is to collect observational, long-term safety and effectiveness data in participants who have received iltamiocel as part of the blinded portion of the REVIVE clinical study.

Protocol Amendment History 1 change

notable Sponsor changed: Peter Belafsky, MD -> University of California, Davis 2026-06-19

Trial Details

NCT Number	NCT07429890
Lead Sponsor	University of California, Davis Collaborators: Cook MyoSite
Conditions	Oropharyngeal Dysphagia
Enrollment	31 participants
Start Date	2026-08-30
Primary Completion	2031-06-30 (estimated)
Study Completion	2032-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-06-18